Global Cancer Biomarker Market Report 2024

Cancer Biomarker Global Market Report 2024 – By Biomarkers Type (Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers), By Profiling Technologies (Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Cytogenetics), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers), By Application (Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 200 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Cancer Biomarker Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Cancer Biomarker Market Definition And Segments

A cancer biomarker refers to a biological molecule present in the blood, tissues, or other bodily fluids, that indicates the presence of normal or abnormal activity, as well as a condition or disease. Cancer biomarkers are used to characterize alterations in the tumor.

The main types of cancer biomarker are protein biomarkers, genetic biomarkers, and other that uses omics technologies, imaging technologies, immunoassay, bioinformatics, and cytogenetics profiling technologies. Protein biomarkers refer to detectable flags in a patient's blood that corresponds with significant events or signal distinct states in a biological process, such as disease progression. Protein biomarkers are used to perform accurate disease diagnosis. The cancer biomarker is used in various cancer such as breast cancer, lung cancer, colorectal cancer, prostate cancer, thyroid cancer, kidney cancer, and other cancers. It is used in diagnostics, research and development, prognostics, risk assessment, and other applications.

The cancer biomarker market covered in this report is segmented –

1) By Biomarkers Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers

2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Cytogenetics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers

4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications

The cancer biomarker market size has grown rapidly in recent years. It will grow from $19.74 billion in 2023 to $22.77 billion in 2024 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to shift to personalized medicine, immunotherapy innovations, regulatory framework evolution, collaborative research efforts, focus on non-coding RNAs.

The cancer biomarker market size is expected to see rapid growth in the next few years. It will grow to $40.66 billion in 2028 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to shift to patient-centric diagnostics, integration of biomarkers in clinical trials, emergence of multiplex biomarker panels, exploration of non-coding RNAs, commercialization of biomarker tests. Major trends in the forecast period include advancements in genomics, precision medicine approaches, liquid biopsies, immunotherapy advancements, artificial intelligence (ai) integration.

The Surging Incidence Of Cancer Fueling Growth In The Cancer Biomarker Market

The rising incidence of cancer is driving the growth of the cancer biomarker market. The cancer incidence rate is the number of new cancers of a specific site/type that occur in a given population during a given year, represented as cancers per 100,000 people at risk. The increasing incidence of cancer is leading to the widespread use of cancer biomarkers because it helps in assessing disease risk, screening for occult primary tumors, identifying benign from malignant signs, or separating one form of malignancy from another. For instance, in January 2022, according to research published by the American Cancer Society, a US-based health organization, in the US, 609,360 cancer deaths and 1.9 million new cancer cases are anticipated in 2022. It is about 1,670 fatalities each day. Therefore, the rising incidence of cancer packaging is expected to propel the growth of the cancer biomarker market in the coming years.

Growing Geriatric Population Fuels Cancer Biomarker Market Expansion

The increase in the geriatric population is expected to boost the growth of the cancer biomarker market going forward. The geriatric population refers to the percentage of people 65 and older to those between the ages of 18 and 64 who are employed. The aging population is at an increased risk of developing cancer, thereby it amplifies the demand for cancer biomarkers by emphasizing the need for early detection, personalized treatment, and targeted interventions. For instance, in October 2022, according to a report published by the World Health Organization (WHO), a Switzerland-based agency responsible for international public health, one in six people is expected to be 60 or older by the year 2030, in the entire world. In the year 2050, the global population of individuals aged 60 years and older is projected to reach 2.1 billion. The number of persons who are 80 years of age or older will increase by 426 million between 2020 and 2050 compared to the current population. Therefore, the increase in the geriatric population is driving the growth of the cancer biomarker market.

Major companies operating in the cancer biomarker market report are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., QIAGEN NV, Illumina Inc., Bio-Rad Laboratories Inc., Abbott Laboratories, bioMérieux SA, Becton Dickinson and Company, Merck & Co. Inc., Bristol-Myers Squibb Company, PerkinElmer Inc., Siemens AG, Exact Sciences Corporation, Novartis AG, Agilent Technologies Inc., Hologic Inc., Myriad Genetics Inc., Foundation Medicine Inc., Guardant Health Inc., Natera Inc., Sysmex Corporation, Biocartis Group NV, NanoString Technologies Inc., Veracyte Inc., Epic Sciences Inc., Cynvenio Biosystems Inc., Genomic Health Inc., Oncocyte Corporation, Exosome Diagnostics Inc., Grail Inc.

The Role Of Technological Advancements In Advancing Biomarker Detection And Analysis

Technological advancement is a key trend gaining popularity in the cancer biomarker market. Major market players are developing advanced technologies, such as artificial intelligence (AI), deep learning (DL), and machine learning (ML), to sustain their position in the cancer biomarker market. These techniques are being used to tackle the problems associated with finding cancer biomarkers, where processing enormous volumes of molecular and imaging data are beyond the capabilities of conventional statistical studies and tools. For instance, in December 2021, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceuticals and diagnostics company, introduced uPath Ki-67 (30-9), uPath ER (SP1), and uPath PR (1E2), three new automated digital pathology algorithms that will be used as a biomarker for image analysis for breast cancer. This image analysis for breast cancer uses pathologist-trained deep learning algorithms to speed up the estimation of Ki-67, ER, and PR tumor cell nuclei positive.

Pioneering Advancements In Cancer Biomarkers Market

Major companies operating in the cancer biomarker market are developing innovative products such as AI-powered cancer diagnostics solutions to meet larger customer bases, more sales, and increase revenue. An AI-powered cancer diagnostics solution refers to a technological system that utilizes artificial intelligence (AI) algorithms, including techniques such as machine learning, deep learning, and other advanced computational methods, to analyze medical data and assist in the detection, diagnosis, and characterization of cancer. For instance, in September 2023, Ibex Medical Analytics, an Israel-based medical technology manufacturer, launched Galen Breast HER2 to assist in the evaluation of biomarker scores for breast cancer. This unique solution aids in patient selection for targeted therapies, employing an innovative AI-powered computational pipeline to analyze HER2 IHC-stained slides. It automatically detects invasive tumor areas, identifies tumor cells, discerns their staining patterns, and swiftly calculates the HER2 IHC score with exceptional accuracy and reproducibility. It supports pathologists in establishing a heightened benchmark for precise and consistent scoring of HER2 (human epidermal growth factor receptor 2) in breast cancer patients. Ibex's Galen Breast HER2, an AI-powered solution for HER2 IHC (immunohistochemistry) scoring, identifies invasive tumor regions and categorizes HER2 expression into four standard classifications (0, 1+, 2+, and 3+) according to the 2018 ASCO/CAP scoring guidelines.

Ge Healthcare Acquired Zionexa

In May 2021, GE Healthcare, a US-based company engaged in diagnostics, therapeutics, and monitoring through intelligent devices, decision support tools, data analytics, and applications, acquired Zionexa for an undisclosed amount. Through this acquisition, GE Healthcare expanded its pipeline of neurology and oncology tracers to aid doctors in treating patients individually. Zionexa is a France-based company that develops in-vivo biomarkers for directing tailored treatments in oncology.

North America was the largest region in the cancer biomaker market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biomarker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cancer biomarker market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer biomarker market consists of sales of epigenetic biomarkers, and metabolic biomarkers for various cancers such as melanoma, leukemia, bladder cancer, non-hodgkin's lymphoma, endometrial cancer, pancreatic cancer, and liver cancer. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The cancer biomarkers market research report is one of a series of new reports from The Business Research Company that provides cancer biomarkers market statistics, including cancer biomarkers industry global market size, regional shares, competitors with a cancer biomarkers market share, detailed cancer biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the cancer biomarkers industry. This cancer biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Cancer Biomarker Market Characteristics

    3. Cancer Biomarker Market Trends And Strategies

    4. Cancer Biomarker Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Cancer Biomarker Market Size and Growth

    5.1. Global Cancer Biomarker Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Cancer Biomarker Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Cancer Biomarker Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Cancer Biomarker Market Segmentation

    6.1. Global Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Protein Biomarkers

    Genetic Biomarkers

    Other Cancer Biomarkers

    6.2. Global Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Omics Technologies

    Imaging Technologies

    Immunoassay

    Bioinformatics

    Cytogenetics

    6.3. Global Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Breast Cancer

    Lung Cancer

    Colorectal Cancer

    Prostate Cancer

    Thyroid Cancer

    Kidney Cancer

    Other Cancers

    6.4. Global Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Diagnostics

    Research And Development

    Prognostics

    Risk Assessment

    Other Applications

    7. Cancer Biomarker Market Regional And Country Analysis

    7.1. Global Cancer Biomarker Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Cancer Biomarker Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Cancer Biomarker Market  

    8.1. Asia-Pacific Cancer Biomarker Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Cancer Biomarker Market  

    9.1. China Cancer Biomarker Market Overview  

    9.2. China Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Cancer Biomarker Market  

    10.1. India Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Cancer Biomarker Market  

    11.1. Japan Cancer Biomarker Market Overview  

    11.2. Japan Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Cancer Biomarker Market  

    12.1. Australia Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Cancer Biomarker Market  

    13.1. Indonesia Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Cancer Biomarker Market  

    14.1. South Korea Cancer Biomarker Market Overview  

    14.2. South Korea Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Cancer Biomarker Market  

    15.1. Western Europe Cancer Biomarker Market Overview

    15.2. Western Europe Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Cancer Biomarker Market  

    16.1. UK Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Cancer Biomarker Market  

    17.1. Germany Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Cancer Biomarker Market  

    18.5. France Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Cancer Biomarker Market  

    19.9. Italy Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Cancer Biomarker Market  

    20.13. Spain Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Cancer Biomarker Market  

    21.1. Eastern Europe Cancer Biomarker Market Overview

    21.2. Eastern Europe Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Cancer Biomarker Market  

    22.1. Russia Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Cancer Biomarker Market  

    23.1. North America Cancer Biomarker Market Overview

    23.2. North America Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Cancer Biomarker Market  

    24.1. USA Cancer Biomarker Market Overview

    24.2. USA Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Cancer Biomarker Market  

    25.1. Canada Cancer Biomarker Market Overview

    25.2. Canada Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Cancer Biomarker Market  

    26.1. South America Cancer Biomarker Market Overview

    26.2. South America Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Cancer Biomarker Market  

    27.1. Brazil Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Cancer Biomarker Market  

    28.1. Middle East Cancer Biomarker Market Overview

    28.2. Middle East Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Cancer Biomarker Market  

    29.1. Africa Cancer Biomarker Market Overview

    29.2. Africa Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Cancer Biomarker Market Competitive Landscape And Company Profiles

    30.1. Cancer Biomarker Market Competitive Landscape

    30.2. Cancer Biomarker Market Company Profiles

    30.2.1. F. Hoffmann-La Roche AG

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Thermo Fisher Scientific Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. QIAGEN NV

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Illumina Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Bio-Rad Laboratories Inc

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Cancer Biomarker Market Competitive Benchmarking

    32. Global Cancer Biomarker Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Cancer Biomarker Market

    34. Cancer Biomarker Market Future Outlook and Potential Analysis

    34.1 Cancer Biomarker Market In 2028 - Countries Offering Most New Opportunities

    34.2 Cancer Biomarker Market In 2028 - Segments Offering Most New Opportunities

    34.3 Cancer Biomarker Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Cancer Biomarker Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Cancer Biomarker Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: F. Hoffmann-La Roche AG Financial Performance
  • Table 76: Thermo Fisher Scientific Inc. Financial Performance
  • Table 77: QIAGEN NV Financial Performance
  • Table 78: Illumina Inc. Financial Performance
  • Table 79: Bio-Rad Laboratories Inc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Cancer Biomarker Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Cancer Biomarker Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Cancer Biomarker Market, Segmentation By Profilling Technologies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: F. Hoffmann-La Roche AG Financial Performance
  • Figure 76: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 77: QIAGEN NV Financial Performance
  • Figure 78: Illumina Inc. Financial Performance
  • Figure 79: Bio-Rad Laboratories Inc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the cancer biomarker market?

A cancer biomarker refers to a biological molecule present in the blood, tissues, or other bodily fluids, that indicates the presence of normal or abnormal activity, as well as a condition or disease. Cancer biomarkers are used to characterize alterations in the tumor. For further insights on the cancer biomarker market, request a sample here

How will the cancer biomarker market drivers and restraints affect the cancer biomarker market dynamics? What forces will shape the cancer biomarker industry going forward?

The cancer biomarker market major growth driver - the surging incidence of cancer fueling growth in the cancer biomarker market. For further insights on the cancer biomarker market, request a sample here

What is the forecast market size or the forecast market value of the cancer biomarker market ?

The cancer biomarker market size has grown rapidly in recent years. It will grow from $19.74 billion in 2023 to $22.77 billion in 2024 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to shift to personalized medicine, immunotherapy innovations, regulatory framework evolution, collaborative research efforts, focus on non-coding rnas. The cancer biomarker market size is expected to see rapid growth in the next few years. It will grow to $40.66 billion in 2028 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to shift to patient-centric diagnostics, integration of biomarkers in clinical trials, emergence of multiplex biomarker panels, exploration of non-coding rnas, commercialization of biomarker tests. Major trends in the forecast period include advancements in genomics, precision medicine approaches, liquid biopsies, immunotherapy advancements, artificial intelligence (ai) integration. For further insights on the cancer biomarker market, request a sample here

How is the cancer biomarker market segmented?

The cancer biomarker market is segmentedThe cancer biomarker market covered in this report is segmented –
1) By Biomarkers Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers
2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Cytogenetics
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers
4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other ApplicationsFor further insights on the cancer biomarker market,
request a sample here

Which region has the largest share of the cancer biomarker market? What are the other regions covered in the report?

North America was the largest region in the cancer biomaker market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biomarker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the cancer biomarker market, request a sample here.

Who are the major players in the cancer biomarker market?

Major companies operating in the cancer biomarker market report are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., QIAGEN NV, Illumina Inc., Bio-Rad Laboratories Inc., Abbott Laboratories, bioMérieux SA, Becton Dickinson and Company, Merck & Co. Inc., Bristol-Myers Squibb Company, PerkinElmer Inc., Siemens AG, Exact Sciences Corporation, Novartis AG, Agilent Technologies Inc., Hologic Inc., Myriad Genetics Inc., Foundation Medicine Inc., Guardant Health Inc., Natera Inc., Sysmex Corporation, Biocartis Group NV, NanoString Technologies Inc., Veracyte Inc., Epic Sciences Inc., Cynvenio Biosystems Inc., Genomic Health Inc., Oncocyte Corporation, Exosome Diagnostics Inc., Grail Inc. For further insights on the cancer biomarker market, request a sample here.

What are the key trends in the cancer biomarker market?

Major trend in the cancer biomarker market - the role of technological advancements in advancing biomarker detection and analysis. For further insights on the cancer biomarker market, request a sample here.

What are the major opportunities in the cancer biomarker market? What are the strategies for the cancer biomarker market?

For detailed insights on the major opportunities and strategies in the cancer biomarker market, request a sample here.

How does the cancer biomarker market relate to the overall economy and other similar markets?

For detailed insights on cancer biomarker market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the cancer biomarker industry?

For detailed insights on the mergers and acquisitions in the cancer biomarker industry, request a sample here.

What are the key dynamics influencing the cancer biomarker market growth? SWOT analysis of the cancer biomarker market.

For detailed insights on the key dynamics influencing the cancer biomarker market growth and SWOT analysis of the cancer biomarker industry, request a sample here.